BSC
VRTX icon

BOLTON SECURITIES CORPORATION’s Vertex Pharmaceuticals VRTX Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.15M Buy
+2,941
New +$1.23M 0.05% 339
2025
Q1 		$1.51M Buy
+3,116
New +$1.45M 0.09% 249

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's VRTX Position: Q3 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2025: 2,941 shares worth $1.15M. The stake represents 0.05% of the portfolio and ranks #339 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in VRTX as recently as Q1 2025.

BOLTON SECURITIES CORPORATION first reported a position in VRTX in Q1 2025 and has held it in 2 quarters since. The position peaked at $1.51M in Q1 2025. 1,528 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • BOLTON SECURITIES CORPORATION held 2,941 shares of Vertex Pharmaceuticals worth $1.15M as of Q3 2025.
  • Vertex Pharmaceuticals was a new BOLTON SECURITIES CORPORATION position in Q3 2025.
  • Vertex Pharmaceuticals made up 0.05% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2025, its #339 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • BOLTON SECURITIES CORPORATION's Vertex Pharmaceuticals position peaked at $1.51M in Q1 2025.
  • 1,528 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2025, filed 12 Nov 2026.